The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market...
The U.S. Food and Drug Administration (FDA) has accepted Regeneron Pharmaceuticals’ (NASDAQ: REGN) supplemental Biologics License Application (sBLA) of EYLEA (aflibercept)...
Biotechnology company Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) recently revealed that its injectable medicine to treat atopic dermatitis, Dupixent, has received approval from...
kg dose, where treatment with NTLA-2001 resulted in 93% mean and 98% maximum serum TTR reduction by day 28 Intellia to host investor event to discuss updated data from Phase 1...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
2022 has started on a different note. After a pandemic-driven market that saw growth stocks soar and indices continue to climb, the onset of a number of factors has slowed the...
Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Buy | Strong Sell | Buy |
| Technical Indicators | Sell | Strong Buy | Buy | Buy | Buy |
| Summary | Neutral | Strong Buy | Buy | Neutral | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.12 | 2.12 | 2.12 | -0.17 | -7.61% | 1.35M | London | |||
| 180.90 | 183.50 | 168.65 | +8.10 | +4.69% | 2.52M | London | |||
| 610.00 | 620.00 | 600.00 | -4.00 | -0.65% | 36.55K | London | |||
| 153.20 | 156.72 | 151.68 | +0.08 | +0.05% | 38.55M | London | |||
| 273.80 | 281.20 | 271.60 | -3.50 | -1.26% | 5.19M | London | |||
| 0.30 | 0.30 | 0.30 | 0.0000 | 0.00% | 0.00 | London | |||
| 544.40 | 550.00 | 539.80 | 0.00 | 0.00% | 0.00 | London | |||
| 0.39 | 0.39 | 0.39 | 0.000 | 0.00% | 4.87M | London | |||
| 593.00 | 608.00 | 579.00 | -13.00 | -2.15% | 112.10K | London | |||
| 65.62 | 66.04 | 63.98 | +0.36 | +0.55% | 10.04M | London | |||
| 0.012 | 0.014 | 0.011 | 0.000 | 0.00% | 0.00 | London | |||
| 105.00 | 105.00 | 105.00 | -5.50 | -5.07% | 435.40K | London | |||
| 508.00 | 508.00 | 508.00 | -3.00 | -0.59% | 3.85K | London | |||
| 0.175 | 0.175 | 0.175 | -0.010 | -5.41% | 7.11M | London | |||
| 290.50 | 287.00 | 287.00 | +3.50 | +1.22% | 40.72K | London |